Harnessing Natural Killer Cell-Mediated Innate Immune Responses for Cancer Treatment: Advances and Challenges
Natural Killer NK Cell Marker (CD3, NCAM1, CD94, NKG2D, SLAMF6, NK-p44) Antibody Panel - Human (ab254014)
The role of natural killer cells in Parkinson's disease | Experimental & Molecular Medicine
Frontiers | CD56 in the Immune System: More Than a Marker for Cytotoxicity?
Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways: Molecular Therapy - Methods & Clinical Development
Cytokine-induced memory-like natural killer cells for cancer immunotherapy | Stem Cell Research & Therapy | Full Text